C-11 PiB ( DrugBank: C-11 PiB )

---

1 disease

ID	Disease name (Link within this page)	Number of trials
127	Frontotemporal lobar degeneration	3

127. Frontotemporal lobar degeneration

---

Clinical trials : 90 /  Drugs : 87 - (DrugBank : 30) / Drug target genes : 39 - Drug target pathways : 88

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT04680130 (ClinicalTrials.gov)	November 1, 2020	3/11/2020	Clinico-Pathologic-Genetic-Imaging Study of Neurodegenerative and Related Disorders	Clinico-Pathologic-Genetic-Imaging Study of Neurodegenerative and Related Disorders	PSP;CBD;PCA;LPA;Semantic Dementia;Semantic Aphasia;Behavioral Variant of Frontotemporal Dementia;FTD;PPA;Apraxia of Speech	Drug: C-11 PiB;Drug: AV1451 Tau	Mayo Clinic	NULL	Enrolling by invitation	21 Years	N/A	All	500		United States
2	NCT01623284 (ClinicalTrials.gov)	March 2010	7/6/2012	PiB PET Scanning in Speech and Language Based Dementias	PiB PET Scanning in Speech and Language Based Dementias	PPA;Primary Progressive Aphasia;Aphasia;Non-fluent Aphasia;Semantic Dementia;Apraxia of Speech;Primary Progressive Nonfluent Aphasia;Progressive Aphasia	Drug: C-11 PiB;Drug: F-18 FDG	Mayo Clinic	NULL	Completed	18 Years	N/A	Both	168	Phase 1	United States
3	NCT00950430 (ClinicalTrials.gov)	April 2008	29/7/2009	Imaging of Brain Amyloid Plaques in the Aging Population	Brain Amyloid Imaging With Pittsburgh Compound B in Normal Aging, Mild Cognitive Impairment, and Dementia	Alzheimer's Disease;Dementia With Lewy Bodies;Frontotemporal Dementia;Vascular Dementia	Drug: Pittsburgh Compound B (C-11 PiB);Drug: F-18 FDG;Drug: Tau (18-F-AV-1451)	Mayo Clinic	National Institute on Aging (NIA)	Enrolling by invitation	30 Years	100 Years	All	8000	Phase 4	United States